Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia

Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy
Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia ( Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy )
6 Dec 2015

ASH 2015: New targeted therapies for haematological malignancies

Dr Robert Hromas - University of Florida, Gainesville, USA
ASH 2015: New targeted therapies for haematological malignancies ( Dr Robert Hromas - University of Florida, Gainesville, USA )
6 Dec 2015

Using epigenetics to manipulate cancer cells

Dr Stephen Nimer - Sylvester Comprehensive Cancer, Miami, USA
Using epigenetics to manipulate cancer cells ( Dr Stephen Nimer - Sylvester Comprehensive Cancer, Miami, USA )
6 Dec 2015

Overcoming the barriers of the P53 dysfunction to cure blood cancers

Dr Guillermina Lozano - MD Anderson Cancer Center, Houston, USA
Overcoming the barriers of the P53 dysfunction to cure blood cancers ( Dr Guillermina Lozano - MD Anderson Cancer Center, Houston, USA )
6 Dec 2015

Experimental oral therapy for ultra high-risk chronic lymphocytic leukaemia shows promise

Prof Stephan Stilgenbauer - University of Ulm, Ulm, Germany
Experimental oral therapy for ultra high-risk chronic lymphocytic leukaemia shows promise ( Prof Stephan Stilgenbauer - University of Ulm, Ulm, Germany )
6 Dec 2015

Study underscores promise of targeted therapies as first-line approach for patients with chronic lymphocytic leukaemia

Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy
Study underscores promise of targeted therapies as first-line approach for patients with chronic lymphocytic leukaemia ( Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy )
6 Dec 2015

First targeted therapy for multiple myeloma effective against hard-to-treat disease

Dr Torben Plesner - Vejle Hospital, University of Southern Denmark, Vejle, Denmark
First targeted therapy for multiple myeloma effective against hard-to-treat disease ( Dr Torben Plesner - Vejle Hospital, University of Southern Denmark, Vejle, Denmark )
6 Dec 2015

First targeted therapy for genetically defined subset of patients with acute myeloid leukaemia significantly improves survival

Dr Richard M. Stone - Dana-Farber Cancer Institute, Boston, USA
First targeted therapy for genetically defined subset of patients with acute myeloid leukaemia  significantly improves survival ( Dr Richard M. Stone - Dana-Farber Cancer Institute, Boston, USA )
6 Dec 2015

Study finds new use for rituximab in acute lymphoblastic leukaemia

Prof Sébastien Maury - Hôpital Henri Mondor, Créteil, France
Study finds new use for rituximab in acute lymphoblastic leukaemia ( Prof Sébastien Maury - Hôpital Henri Mondor, Créteil, France )
6 Dec 2015

First targeted therapy for multiple myeloma effective against hard-to-treat disease

Dr Torben Plesner - Vejle Hospital, Vejle, Denmark
First targeted therapy for multiple myeloma effective against hard-to-treat disease ( Dr Torben Plesner - Vejle Hospital, Vejle, Denmark )
6 Dec 2015

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival

Dr Richard Stone - Dana Farber Cancer Institute, Boston, USA
First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival ( Dr Richard Stone - Dana Farber Cancer Institute, Boston, USA )
6 Dec 2015

Immunotherapy makes patients’ tumours "melt away"

Dr Joshua Brody - Mount Sinai Medical Center, New York, USA
Immunotherapy makes patients’ tumours "melt away" ( Dr Joshua Brody - Mount Sinai Medical Center, New York, USA )
6 Dec 2015